NCT01468285View on ClinicalTrials.gov

The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Gait or Balance Disorder Problems
Interventions
DRUG

betahistine dihydrochloride

betahistine dihydrochloride 24 mg tablet b.i.d. six weeks treatment

OTHER

placebo

placebo tablets b.i.d., six weeks treatment

Trial Locations (2)

169608

Site Reference ID/Investigator# 63545, Singapore

308433

Site Reference ID/Investigator# 63544, Singapore

All Listed Sponsors
lead

Abbott Products

INDUSTRY

NCT01468285 - The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow | Biotech Hunter | Biotech Hunter